Quality Control Study of Different Products from Famotidine Tablets in the Iraqi Market by Nizar Jassem

“…In the Iraqi market, famotidine tablets are available from different pharmaceutical companies. As a result, regular pre-marketing quality testing is required to check the quality and identify which product might safely substitute the innovator product in the event of the innovator brand's unavailability or high cost. …”
Get full text

Research Capacity Strengthening in Low and Middle Income Countries - An Evaluation of the WHO/TDR Career Development Fellowship Programme. by Michael Käser, Christine Maure, Beatrice M M Halpaap, Mahnaz Vahedi, Sara Yamaka, Pascal Launois, Núria Casamitjana

“…The programme provides a year-long training experience for qualified researchers from low and middle income countries at pharmaceutical companies or product development partnerships. …”
Get full text

القدرة التنافسية للصناعات الدوائية الأردنية(القياس والتحليل) by يوسف محمود, محمد صقر, عبدالحكيم النسور

“…This paper also studies the relation between the competitiveness index of companies and other  factors, such as capital, production age, the number of different medical productions, the expenditure on scientific research, the number of employees in pharmaceutical companies and in scientific research .and marketing. …”
Get full text

Distribution of bacterial contamination in non-sterile pharmaceutical materials and assessment of its risk to the health of the final consumers quantitatively by Mostafa Essam Eissa

“…The applied risk can be used as a milestone for setting goals by pharmaceutical companies to improve the safety of medicinal products microbiologically and to identify the major sources of the risk to work on it in order to deliver safe drugs to the customers.…”
Get full text

Optimized Methods for Analytical and Functional Comparison of Biosimilar mAb Drugs: A Case Study for Avastin, Mvasi, and Zirabev by Büşra Gürel, Eda Çapkın, Ayhan Parlar, Aylin Özkan, Meltem Çorbacıoğlu, Duygu Emine Dağlikoca, Meral Yüce

“…Bevacizumab is a humanized therapeutic monoclonal antibody used to reduce angiogenesis, a hallmark of cancer, by binding to VEGF-A. Many pharmaceutical companies have developed biosimilars of Bevacizumab in the last decade. …”
Get full text

Why does the world need another rotavirus vaccine? by Richard L Ward, Monica M McNeal, A Duncan Steele

“…The purpose was to discuss, evaluate, and weigh the importance of additional rotavirus vaccine candidates following the successful international licensure of rotavirus vaccines by two major pharmaceutical companies (GlaxoSmithKline and Merck) that had been in development for many years. …”
Get full text

The study of socio economic factors’ influence on the capacity dynamics of the pharmaceutical market in contracting conditions by А. А. Kotvitska, V. H. Kostiuk

“…For the effective functioning of pharmaceutical companies in the current economic conditions it is necessary to carry out product policy aimed to expanding the range of medicines that are most popular. …”
Get full text

Bulgarian general population attitude to mandatory COVID-19 vaccination: A nationwide cross-sectional study by Rouzha Pancheva, Rositsa Chamova, Maria Rohova, Nikolay Mihaylov, Stanislava Hadzhieva, Miglena Kolarova, Eliyana Ivanova, Nikolina Radeva, Tsonko Paunov, Adamos Hadjipanayis

“…Trust in general practitioners and pharmaceutical companies also emerged as influential factors. …”
Get full text

What is the impact of the ACE gene insertion/deletion (I/D) polymorphism on the clinical effectiveness and adverse events of ACE inhibitors? – Protocol of a systematic review by Steurer J, Puhan MA, Scharplatz M, Bachmann LM

“…In addition, authors of trials, experts in pharmacogenetics and pharmaceutical companies will be contacted for further published or unpublished data. …”
Get full text

Tailoring enhanced production and identification of isoflavones in the callus cultures of Pueraria thomsonii Benth and its model verification using response surface methodology (RS... by Yu Li, Pachaiyappan Saravana Kumar, Yu Liu, Jiao Qiu, Yalan Ran, Mingyuan Yuan, Xinyue Fang, Xuhui Tan, Renjun Zhao, Ji zhu, Meijun He

“…As far as the authors are concerned, this is the first report on production of daidzin, puerarin and daidzein at higher yield at laboratory level for a wide range of applications in future food, medicinal and pharmaceutical companies.…”
Get full text

Current Status of Antimicrobial Drug Use in Japanese Companion Animal Clinics and the Factors Associated With Their Use by Kohei Makita, Nami Sugahara, Kazuhiro Nakamura, Takeshi Matsuoka, Masato Sakai, Yutaka Tamura

“…The Japanese Veterinary Antimicrobial Resistance Monitoring (JVARM) system monitors the sale of veterinary antimicrobial drugs by pharmaceutical companies, and the sale of human drugs by principal wholesale companies to companion animal (dogs and cats) clinics. …”
Get full text

Eight years of sales surveillance of antimicrobials for veterinary use in Germany-What are the perceptions? by Lydia M Köper, Christoph Bode, Alice Bender, Inke Reimer, Thomas Heberer, Jürgen Wallmann

“…Since then, pharmaceutical companies and wholesalers have been legally obliged to report annual volumes of veterinary antimicrobial products sold to veterinary practices or clinics located in Germany. …”
Get full text

The new Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12 months by Timothy Beukelman, Yukiko Kimura, Norman T. Ilowite, Kelly Mieszkalski, Marc D. Natter, Grendel Burrell, Brian Best, Jason Jones, Laura E. Schanberg, For the CARRA Registry Investigators

“…The CARRA Registry provides safety surveillance data to pharmaceutical companies to satisfy their regulatory requirements, and several independently-funded sub-studies that use the Registry infrastructure are underway. …”
Get full text

COVID-19 vaccination acceptability and experiences among people who inject drugs in San Diego County by Chad J. Valasek, Samantha A. Streuli, Heather A. Pines, Maria Luisa Mittal, Steffanie A. Strathdee, Carlos F. Vera, Alicia Harvey-Vera, Angela R. Bazzi

“…We identified three key barriers to COVID-19 vaccination: (1) low perceived risk of COVID-19 (or belief in natural immunity), (2) institutional distrust (e.g., of pharmaceutical companies and government agencies that “rushed” vaccine development, approval, and distribution), and (3) conflicting information from news, social media, and peers. …”
Get full text

The Effect of the Arrangement to Implement Local Working of Patents on the Policy of State’s Responsibility in Fulfilling Public Accessibility Rights to Patent Medicine by Rahayu Rahayu, Kholis Roisah, Diastama Anggita Ramadhan, Leony Sondang Suryani

“…Indonesia as a country rich in bio-diversity needs mandatory policies for national pharmaceutical companies to develop raw materials for biopharmaceutical medicine.…”
Get full text

The costs of disorders of the brain in Switzerland: an update from the European Brain Council Study for 2010 by Andreas Maercker, Axel Perkonigg, Martin Preisig, Karl Schaller, Michael Weller, Cost of Disorders of the Brain in Europe Study Group

“…We suggest coordinated research and preventive measures coordinated between governmental bodies, private health-care and pharmaceutical companies. …”
Get full text

A qualitative study of COVID-19 vaccine intentions and mistrust in Black Americans: Recommendations for vaccine dissemination and uptake by Lu Dong, Laura M. Bogart, Priya Gandhi, James B. Aboagye, Samantha Ryan, Rosette Serwanga, Bisola O. Ojikutu

“…Perceived barriers to COVID-19 vaccination included structural barriers to access (e.g., transportation, technology) and medical mistrust (e.g., towards the vaccines themselves, the government, healthcare providers and healthcare systems, and pharmaceutical companies) stemming from historical and contemporary systematic racism against Black communities. …”
Get full text

Reporting on the opioid crisis (2000–2018): role of The Globe and Mail, a Canadian English-language newspaper in influencing public opinion by Amanda My Linh Quan, Lindsay A. Wilson, Salima S. Mithani, David T. Zhu, A. Brianne Bota, Kumanan Wilson

“…Content analysis of the articles revealed common social representations attributing responsibility to pharmaceutical companies, physicians, and foreign countries. …”
Get full text

Attitudes of medical students towards conflict of interest: a national survey in France. by Bruno Etain, Lydia Guittet, Nicolas Weiss, Vincent Gajdos, Sandrine Katsahian

“…The law also requires pharmaceutical companies to publicize financial and other benefits given to medical students. …”
Get full text

DeepLPI: a novel deep learning-based model for protein–ligand interaction prediction for drug repurposing by Bomin Wei, Yue Zhang, Xiang Gong

“…Abstract The substantial cost of new drug research and development has consistently posed a huge burden for both pharmaceutical companies and patients. In order to lower the expenditure and development failure rate, repurposing existing and approved drugs by identifying interactions between drug molecules and target proteins based on computational methods have gained growing attention. …”
Get full text